
Cumberland Pharmaceuticals Inc.
CPIXHealthcare|Drug Manufacturers - Specialty & Generic|US
$5.22
+0.21 (+4.19%)
Tangible Book / Share
$1.14
Cash / Share
$0.26
Clinical Trials (68)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT06119061 Telavancin Blood and Cerebrospinal Fluid Concentrations in Patients With External Ventricular Drainage | Subarachnoid Hemorrhage, Aneurysmal | P4 | Recruiting | 20 | Open-label | Telavancin Injection |
| NCT02682511 Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension | Scleroderma, Diffuse, Scleroderma, Systemic | P2 | Active | 34 | RCT, Double-blind | Oral Ifetroban, Oral Placebo |
| NCT05571059 Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF) | Idiopathic Pulmonary Fibrosis | P2 | Recruiting | 128 | RCT, Double-blind | Ifetroban Sodium, Placebo |
| NCT07387666 Imaging Acetadote Metabolism in Glioblastoma | Glioblastoma, GBM | Early P1 | Recruiting | 10 | Open-label | Acetadote |
| NCT01707251 Intravenous Ibuprofen for Laparoscopic Bariatric Surgery | Obesity | P4 | Completed | 100 | RCT, Double-blind | Intravenous Ibuprofen, Saline |
| NCT01334957 Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen | Pain | P4 | Completed | 300 | Open-label | Intravenous ibuprofen |
| NCT01530880 Aggressive Fever Control With Intravenous Ibuprofen After Non-traumatic Brain Hemorrhage | Fever | P4 | Terminated | 35 | RCT, Open-label | Intravenous Ibuprofen, Acetaminophen (Standard of Care) |
| NCT01901393 Efficacy of Intravenous Ibuprofen Compared to Intravenous Ketorolac for Pain Control Following Arthroscopic Knee Surgery | Pain | P4 | Completed | 100 | RCT, Double-blind | IV ibuprofen, Ketorolac |
| NCT02583399 Safety and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients | Pain, Fever | P4 | Completed | 30 | Open-label | Ibuprofen |
| NCT00939913 Effect of Intravenous Acetadote on Incidence of Contrast Induced Nephropathy | Nephropathy | P4 | Unknown | 400 | RCT, Double-blind | intravenous NAC, Placebo |
| NCT01334944 Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen | Pain, Fever | P4 | Completed | 150 | Open-label | Intravenous ibuprofen |
| NCT00435591 A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia | Hyponatremia, Euvolemia | P4 | Completed | 121 | RCT, Double-blind | Conivaptan, placebo |
| NCT01773005 Caldolor Versus Caldolor Plus OFIRMEV in Total Knee or Hip Arthroplasty Surgeries | Pain | P4 | Completed | 78 | RCT, Single-blind | Ofirmev, Caldolor |
| NCT01514175 A Pilot Study Comparing the Analgesic Efficacy of IV Ibuprofen and IV Ketorolac | Chronic Pelvic Pain | P4 | Unknown | 50 | Double-blind | IV Ibuprofen, IV Ketorolac |
| NCT03172793 Telavancin Pharmacokinetics in Cystic Fibrosis Patients | Cystic Fibrosis | P4 | Completed | 18 | Open-label | Telavancin Injection |
| NCT01650519 A Pilot Study to Determine the Efficacy of Intravenous Ibuprofen for Pain Control Following Arthroscopic Knee Surgery | Arthroscopic Knee Surgery | P4 | Completed | 51 | RCT, Double-blind | IV ibuprofen, IV ketorolac |
| NCT00712543 A Preference Study Comparing Kristalose® and Liquid Lactulose | Constipation | P4 | Completed | 50 | RCT, Open-label | lactulose (Kristalose®), liquid lactulose |
| NCT00470743 Comparing Ibuprofen And Indomethacin For The Treatment Of The Patent Ductus Arteriosus in Very Premature Babies | Ductus Arteriosus, Patent, Very Low Birth Weight Infants | P4 | Withdrawn | — | RCT, Open-label | Ibuprofen, Indomethacin |
| NCT00380575 Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia | Hyponatremia | P3 | Completed | 84 | RCT, Double-blind | YM087 |
| NCT00492037 Study of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or Hypervolemic Hyponatremia | Hyponatremia | P3 | Completed | 83 | RCT, Double-blind | YM087 oral |
| NCT01297829 Does Preoperative Caldolor Decrease the Requirement for Postoperative Narcotics | Postoperative Pain | P3 | Unknown | 51 | RCT, Double-blind | Intravenous Ibuprofen |
| NCT00606489 Efficacy and Safety Study of Caldolor (Intravenous Ibuprofen) in Hospitalized Adult and Pediatric Burn Patients | Burns | P3 | Completed | 61 | RCT, Double-blind | Caldolor, Placebo |
| NCT00107978 Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus | Staphylococcal Skin Infection | P3 | Completed | 1,035 | RCT, Double-blind | Telavancin, Vancomycin |
| NCT00225732 Trial of Caldolor for Treatment of Pain in Post-Operative Adult Patients | Pain | P3 | Completed | 319 | RCT, Double-blind | Intravenous ibuprofen |
| NCT02208063 A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial | Bacteremia | P3 | Terminated | 121 | RCT, Open-label | Telavancin, Vancomycin, Daptomycin, Synthetic penicillin, Cefazolin |
| NCT00470600 Efficacy and Safety Study of Caldolor (IV Ibuprofen) in Hospitalized Adult Orthopedic Patients | Pain | P3 | Completed | 185 | RCT, Double-blind | Caldolor |
| NCT00379847 An Open-Label Study of YM087 (Conivaptan) in Patients With Euvolemic or Hypervolemic Hyponatremia | Hyponatremia | P3 | Completed | 251 | RCT, Open-label | conivaptan |
| NCT01131000 Efficacy, Safety, and Pharmacokinetics of Intravenous Ibuprofen in Adult Febrile Patients | Fever | P3 | Completed | 123 | RCT, Double-blind | Ibuprofen, Ibuprofen, Ibuprofen |
| NCT01332253 Safety and Efficacy of Intravenous Ibuprofen for Treatment of Pain in Pediatric Patients Undergoing Tonsillectomy | Tonsillectomy | P3 | Completed | 161 | RCT, Double-blind | Intravenous ibuprofen |
| NCT00225706 A Study of Caldolor in Hospitalized Febrile Pediatric Patients | Fever | P3 | Completed | — | RCT, Open-label | Caldolor |
| NCT00107952 Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus | Bacterial Pneumonia | P3 | Completed | 761 | RCT, Double-blind | Telavancin, Vancomycin |
| NCT01118663 Safety and Efficacy Study of a New Formulation of Acetylcysteine Injection | Acetaminophen Overdose | P3 | Terminated | 17 | RCT, Double-blind | Acetadote EF (Ethylenediaminetetraacetic Acid (EDTA) - Free), Acetadote |
| NCT01002573 Safety, Efficacy, and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients | Fever | P3 | Completed | 118 | RCT, Open-label | ibuprofen, acetaminophen |
| NCT00843986 Safety and Efficacy of Conivaptan in Hyponatremic Patients With Symptomatic Acute Decompensated Heart Failure (ADHF) | Hyponatremia, Acute Decompensated Heart Failure | P3 | Terminated | 9 | RCT, Double-blind | conivaptan, placebo |
| NCT01451411 A Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous Conivaptan (Vaprisol®) in Pediatric Subjects With Euvolemic or Hypervolemic Hyponatremia | Hyponatremia | P3 | Terminated | 4 | RCT, Double-blind | Conivaptan hydrochloride, Placebo |
| NCT00124020 Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus | Bacterial Pneumonia | P3 | Completed | 771 | RCT, Double-blind | Telavancin, Vancomycin |
| NCT00091819 Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus | Staphylococcal Skin Infection | P3 | Completed | 862 | RCT, Double-blind | Telavancin, Vancomycin |
| NCT00478192 Study of Efficacy & Safety for 3 Infusion Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia | Hyponatremia | P3 | Completed | 50 | RCT, Double-blind | Conivaptan, Placebo |
| NCT03028350 Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD) | Asthma, Aspirin-Induced | P2 | Completed | 54 | RCT, Double-blind | Ifetroban Oral Capsule, Placebo Oral Capsule |
| NCT02802228 Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients | Portal Hypertension, Liver Cirrhosis | P2 | Completed | 30 | RCT, Double-blind | Ifetroban, Placebo |
| NCT00592475 A Study to Assess the Safety and Effects of Intravenous (IV) Conivaptan on the Hepatic Hemodynamic Response in Cirrhotic Patients | Liver Cirrhosis | P2 | Completed | 20 | RCT, Double-blind | conivaptan, Placebo |
| NCT03694249 Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic Recurrence | Malignant Solid Tumor | P2 | Unknown | 30 | RCT, Double-blind | Ifetroban Sodium |
| NCT03611010 Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients | Hypercholesterolemia, Dyslipidemias | P2 | Completed | 40 | Open-label | Atorvastatin injection |
| NCT00061633 Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI) | Infections, Gram-Positive Bacterial, Abscess | P2 | Completed | 169 | RCT, Double-blind | Telavancin, Vancomycin or antistaphylococcal penicillin |
| NCT02123017 Efficacy and Safety of Bisacodyl and Lactulose as a Preparation for Colonoscopy | Colonoscopy Preparation | P2 | Completed | 32 | Single-blind | 90 grams of Crystalline Lactulose, 135 grams of Crystalline Lactulose, 180 grams of Crystalline Lactulose |
| NCT02216357 Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease | Aspirin Exacerbated Respiratory Disease (AERD) | P2 | Completed | 19 | RCT, Double-blind | Ifetroban, Oral Capsule, Placebo, Oral Capsule |
| NCT03340675 Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy | Duchenne Muscular Dystrophy Cardiomyopathy, Cardiomyopathy, Dilated | P2 | Completed | 46 | RCT, Double-blind | Ifetroban, Placebo |
| NCT00077675 Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI) | Infections, Gram-positive Bacterial | P2 | Completed | 201 | RCT, Double-blind | Telavancin, vancomycin or antistaphylococcal penicillin |
| NCT01650870 Safety, Efficacy, and Patient Preference of Split-Dose Crystalline Lactulose as a Preparation for Colonoscopy in Adults | Colonoscopy | P2 | Completed | 40 | RCT, Single-blind | Crystalline Lactulose |
| NCT01887470 2 Regimens of Lactulose for Colonoscopy Preparation in Adults | Colonoscopy Preparation | P2 | Completed | 55 | RCT, Double-blind | Full dose preparation, Split dose preparation |
| NCT03962855 Thromboxane Receptor Antagonist to Improve Endothelial Function | Cardiovascular Diseases, Vascular Dilation | P2 | Completed | 57 | RCT, Double-blind | Ifetroban Sodium, Placebo |
| NCT00780962 N-Acetylcysteine to Prevent Radiocontrast Nephropathy in Emergency Department Patients | Radiocontrast Nephropathy | P2 | Completed | 399 | RCT, Double-blind | N-Acetylcysteine (NAC), 0.9% Sodium-chloride |
| NCT01436500 Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients | Hepatorenal Syndrome | P2 | Completed | 55 | RCT, Double-blind | Ifetroban Injection, Placebo |
| NCT02614937 Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion | Retinal Vein Occlusion, Macular Edema | P1P2 | Completed | 20 | RCT, Open-label | ranibizumab, Squalamine Lactate Ophthalmic Solution, 0.2% |
| NCT00062647 Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia | Gram-Positive Bacterial Infections | P2 | Completed | 60 | RCT, Double-blind | Telavancin, Vancomycin, nafcillin, oxacillin, or cloxacillin |
| NCT00057356 Safety and Efficacy Study of YM087 (Conivaptan) in Patients With Acute Decompensated Heart Failure | Chronic Heart Failure | P2 | Completed | 170 | RCT, Double-blind | conivaptan, placebo |
| NCT01370148 A Study to Assess the Effect of Severe Hepatic Impairment on the Pharmacokinetics of Intravenous Conivaptan | Liver Disease | P1 | Completed | 17 | Open-label | conivaptan hydrochloride |
| NCT01238796 A Study to Evaluate the Effect of Renal Function on the Biological Activity of Telavancin | Kidney Diseases, End Stage Renal Disease | P1 | Completed | 45 | Open-label | telavancin |
| NCT02013141 Telavancin Pediatric PK Study (Ages >12 Months to 17 Years) | Gram-Positive Bacterial Infections | P1 | Terminated | 22 | Open-label | Telavancin |
| NCT01256541 Kristalose as Bowel Evacuant Prior to Colonoscopy | Bowel Evacuant Prior to Colonoscopy | P1 | Completed | 20 | Open-label | Kristalose |
| NCT00867880 Pharmacokinetic Study Of Ibuprofen Injection (IVIb) In Healthy Adult Subjects | Healthy | P1 | Completed | 12 | RCT, Double-blind | IVIb |
| NCT00851227 Study to Compare Conivaptan in Subjects With Mild & Moderate Liver Impairment Versus Subjects With Normal Liver Function | Liver Disease, Hyponatremia | P1 | Completed | 26 | Open-label | conivaptan hydrochloride |
| NCT00887627 Study to Compare Conivaptan Pharmacokinetics in Subjects With Mild & Moderate Kidney Function Impairment to Subjects With Normal Kidney Function | Kidney Diseases, Hyponatremia | P1 | Completed | 25 | Open-label | conivaptan hydrochloride |
| NCT00889538 Study of Glutathione, Vitamin C and Cysteine in Children With Autism and Severe Behavior Problems | Autism, Severe Behavior Disorder | N/A | Completed | 24 | RCT, Double-blind | placebo, glutathione, glutathione, vit C and NAC |
| NCT02288234 Telavancin Observational Use Registry (TOUR) | Hospital Acquired Bacterial Pneumonia, Complicated Skin and Skin Structure Infections | Completed | 1,063 | — | Vibativ | |
| NCT01130324 VIBATIV Pregnancy Registry | Pregnancy | Withdrawn | — | — | VIBATIV | |
| NCT03494556 Prehospital Translation of Chest Pain Tools | Acute Coronary Syndrome, Pulmonary Embolism | Completed | 365 | — | — | |
| NCT01526551 A Study to Compare the Impact of a School Based HPV Program on Vaccination Uptake and Completion Rates | Human Papillomavirus | N/A | Completed | 935 | Open-label | — |